Outcome after curative resection for a huge (≥10 cm) hepatocellular carcinoma and prognostic significance of gross tumor classification

被引:98
|
作者
Choi, Gi Hong [1 ,2 ]
Han, Dai Hoon [1 ,2 ]
Kim, Dong Hyun [1 ,2 ]
Choi, Sae Byeol [1 ,2 ]
Kang, Chang Moo [1 ,2 ]
Kim, Kyung Sik [1 ,2 ]
Choi, Jin Sub [1 ,2 ]
Park, Young Nyun [2 ,3 ]
Park, Jun Yong [2 ,4 ]
Kim, Do Young [2 ,4 ]
Han, Kwang-Hyub [2 ,4 ]
Chon, Chae Yoon [2 ,4 ]
Lee, Woo Jung [1 ,2 ]
机构
[1] Yonsei Univ Hlth Syst, Dept Surg, Seoul 120752, South Korea
[2] Yonsei Univ Hlth Syst, Dept Internal Med, Seoul 120752, South Korea
[3] Yonsei Univ Hlth Syst, Dept Pathol, Seoul 120752, South Korea
[4] Yonsei Univ Hlth Syst, Yonsei Liver Canc Special Clin, Seoul 120752, South Korea
关键词
Hepatocellular carcinoma; Huge; Surgical resection; Prognosis; Gross tumor type; HEPATIC RESECTION; SURGICAL-TREATMENT; LARGER; MANAGEMENT; RECURRENCE; INVASION; SELECTION; SURVIVAL; SURGERY; RISK;
D O I
10.1016/j.amjsurg.2008.09.019
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND AND OBJECTIVES: The purpose of this study was to investigate the surgical outcomes in patients with huge (>= 10 cm.) hepatocellular carcinoma (HCC). METHODS: Clinicopathological features and surgical Outcomes of 50 patients with huge HCC who underwent curative resection (group A) were compared with 447 patients with smaller tumors (group 13). In group A, we investigated prognostic factors. RESULTS: Group A patients had a higher incidence of alpha-fetoprotein at more than 1,000 IU/mL microscopic vascular invasion, and advanced stage tumors. The disease-free survival of group A was significantly worse than group B. The rates of initial extrahepatic recurrence and early recurrence were higher in group A. The 5 year-overall survival of group A was 40.2%, significantly lower than that of group B (65.9% at 5 years). In group A. multivariate analysis revealed that the presence of single nodular type tumors was the only good prognostic factor for survival. CONCLUSIONS: Huge HCCs exhibit a more aggressive clinical behavior and worse survival. However, because the outcome of surgical treatment is far better than that Of nonsurgical treatment, resection should be actively considered for patients with huge HCC. A single nodular type tumor is the best candidate for surgical resection. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:693 / 701
页数:9
相关论文
共 50 条
  • [21] Nomograms Incorporating the CNLC Staging System Predict the Outcome of Hepatocellular Carcinoma After Curative Resection
    Liao, Rui
    Wei, Xu-Fu
    Che, Ping
    Yin, Kun-Li
    Liu, Lei
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [22] Gross classification of solitary small hepatocellular carcinoma on preoperative computed tomography: Prognostic significance after radiofrequency ablation
    Fu, Xu
    Mao, Liang
    Tang, Min
    Yan, Xiaopeng
    Qiu, Yudong
    He, Jian
    Zhou, Tie
    HEPATOLOGY RESEARCH, 2016, 46 (04) : 298 - 305
  • [23] Early Recurrence in Large Hepatocellular Carcinoma after Curative Hepatic Resection: Prognostic Significance and Risk Factors
    Zhou, Li
    Rui, Jing-An
    Wang, Shao-Bin
    Chen, Shu-Guang
    Qu, Qiang
    HEPATO-GASTROENTEROLOGY, 2014, 61 (135) : 2035 - 2041
  • [24] Sorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma
    Li, Jiang
    Hou, Yu
    Cai, Xiao-Bei
    Liu, Bin
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (15) : 4034 - 4040
  • [25] Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection
    Feng, Yuemin
    Wu, Hao
    Huang, Daniel Q.
    Xu, Chenghui
    Zheng, Hang
    Maeda, Mayumi
    Zhao, Xinya
    Wang, Le
    Xiao, Feng
    Lv, Huanran
    Liu, Tiantian
    Qi, Jianni
    Li, Jie
    Zhong, Ning
    Wang, Chuanxi
    Feng, Hong
    Liang, Bo
    Ren, Wanhua
    Qin, Chengyong
    Nguyen, Mindie H.
    Zhu, Qiang
    EUROPEAN RADIOLOGY, 2020, 30 (11) : 6357 - 6368
  • [26] Correlation and prognostic value of osteopontin and Bcl-2 in hepatocellular carcinoma patients after curative resection
    Deng, Biao
    Zhang, Xiao-Fei
    Zhu, Xu-Chao
    Huang, Hua
    Jia, Hu-Liang
    Ye, Qing-Hai
    Dong, Qiong-Zhu
    Qin, Lun-Xiu
    ONCOLOGY REPORTS, 2013, 30 (06) : 2795 - 2803
  • [27] Clinicopathological Predictors of Poor Survival and Recurrence After Curative Resection in Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis
    Zhou, Li
    Rui, Jing-An
    Wang, Shao-Bin
    Chen, Shu-Guang
    Qu, Qiang
    PATHOLOGY & ONCOLOGY RESEARCH, 2015, 21 (01) : 131 - 138
  • [28] ATAD2 as a Poor Prognostic Marker for Hepatocellular Carcinoma after Curative Resection
    Hwang, Hye Won
    Ha, Sang Yun
    Bang, Heejin
    Park, Cheol-Keun
    CANCER RESEARCH AND TREATMENT, 2015, 47 (04): : 853 - 861
  • [29] Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection
    Yamamura, Kazuo
    Sugimoto, Hiroyuki
    Kanda, Mitsuro
    Yamada, Suguru
    Nomoto, Shuji
    Nakayama, Goro
    Fujii, Tsutomu
    Koike, Masahiko
    Fujiwara, Michitaka
    Kodera, Yasuhiro
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2014, 21 (09) : 682 - 688
  • [30] A novel and validated prognostic nomogram based on liver fibrosis and tumor burden for patients with hepatocellular carcinoma after curative resection
    Huang, Jin-Long
    Fu, Yi-Peng
    Jing, Chu-Yu
    Yi, Yong
    Sun, Jian
    Gan, Wei
    Lu, Zhu-Feng
    Zhou, Jian
    Fan, Jia
    Qiu, Shuang-Jian
    JOURNAL OF SURGICAL ONCOLOGY, 2018, 117 (04) : 625 - 633